Minister opens new clinical trials centre in Midland
The Minister for Medical Research, the Hon Stephen Dawson MLC, officially opened the Institute for Respiratory Health’s new Centre for Clinical Trials in Midland.
The strategic expansion brings cutting-edge research and innovative treatments closer to the Midland community. It addresses the urgent need for new cures and treatments for chronic lung diseases – the second biggest killer of Australians in the country.
Emeritus Professor Geoff Stewart, Director of the Institute said, “The Centre for Clinical Trials is designed to serve the Midland community and surrounding area.
“It offers a dedicated healthcare facility where patients can participate in groundbreaking clinical trials, potentially access life-changing treatments before they are widely available to the general public.
“It’s also part of our strategy to make Western Australia a lung research superpower – the best place in the world to do respiratory research and to fight for better respiratory outcomes for Western Australians.”
Hundreds of trial participants are expected to participate in clinical trials at the centre, which is located in the Icon Cancer Centre, annually.
Chronic lung conditions affect one in three Australians, with 45 loved ones lost to lung conditions every day.
The Centre for Clinical Trials Midland is the Institute’s second respiratory research hub, with another facility based at the Harry Perkins Institute of Medical Research in Nedlands.
The Institute has been leading global respiratory clinical trials for more than two decades. It has collaborated with more than 2,400 volunteers and conducted more than 250 respiratory research studies across conditions such as asthma, COPD and bronchiectasis to name a few.
The Hon Stephen Dawson MLC said, “The COVID-19 pandemic has shown the world just how important clinical trials are, not only in fighting diseases but also in driving medical innovation and economic growth.
“Western Australia is a global leader in clinical trials research and this new centre will enable us to connect the Midland region to potentially life-saving clinical trial opportunities and drive new breakthroughs to change the lives of those with lung disease.”
The strategic expansion brings cutting-edge research and innovative treatments closer to the Midland community. It addresses the urgent need for new cures and treatments for chronic lung diseases – the second biggest killer of Australians in the country.
Emeritus Professor Geoff Stewart, Director of the Institute said, “The Centre for Clinical Trials is designed to serve the Midland community and surrounding area.
“It offers a dedicated healthcare facility where patients can participate in groundbreaking clinical trials, potentially access life-changing treatments before they are widely available to the general public.
“It’s also part of our strategy to make Western Australia a lung research superpower – the best place in the world to do respiratory research and to fight for better respiratory outcomes for Western Australians.”
Hundreds of trial participants are expected to participate in clinical trials at the centre, which is located in the Icon Cancer Centre, annually.
Chronic lung conditions affect one in three Australians, with 45 loved ones lost to lung conditions every day.
The Centre for Clinical Trials Midland is the Institute’s second respiratory research hub, with another facility based at the Harry Perkins Institute of Medical Research in Nedlands.
The Institute has been leading global respiratory clinical trials for more than two decades. It has collaborated with more than 2,400 volunteers and conducted more than 250 respiratory research studies across conditions such as asthma, COPD and bronchiectasis to name a few.
The Hon Stephen Dawson MLC said, “The COVID-19 pandemic has shown the world just how important clinical trials are, not only in fighting diseases but also in driving medical innovation and economic growth.
“Western Australia is a global leader in clinical trials research and this new centre will enable us to connect the Midland region to potentially life-saving clinical trial opportunities and drive new breakthroughs to change the lives of those with lung disease.”
Click here for more information on trials available at both the Midland and Midland sites.